Cassava Sciences to discontinue all efforts to develop simufilam in Alzheimer’s
We are disappointed that the results of REFOCUS-ALZ and RETHINK-ALZ showed no treatment benefit for patients with mild-to-moderate Alzheimer’s ...
Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data
Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...
inkbotdesign.com21d
The Apple Logo History, Meaning and Evolution
From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...
Metro22d
Barclays announces £12,500,000 outage payout for millions of customers — are you eligible?
After widespread outages on its app and website, Barclays has been ordered to pay out a total £12.5 million in compensation to those affected. In February, a number of banks’ mobile payment ...